Canadian wellness model Cannanda claims to have developed a CBD-like hemp extract —dubbed “CB2” —that they are saying ameliorates lots of the main points affecting CBD’s effectiveness, security, and authorized standing.
In a press launch protecting the rise of CB2 oil, Cannanda co-founder Dr. Lee Know explains, “The good thing about CB2 oil is that it side-steps each downside that plagues CBD … like opposed drug interactions, unanswered questions concerning security, undisclosed THC, and different high quality points.”
Dr. Know then went on to tout CB2’s success fee (as reported by customers in survey knowledge), which is allegedly double that of CBD, citing a 60-70% success fee for the previous and a 33% success fee for the latter.
So, what precisely is CB2 fabricated from that permits it to reflect the consequences of CBD whereas sidestepping these points?
Terpenes. Current in lots of vegetation and fruits, terpenes are probably bioactive compounds that strongly affect how the plant will odor.
As well as, terpenes like linalool and limonene can elicit calming and/or mood-stabilizing results—see this beginner-friendly breakdown on terpenes should you’d prefer to dig into the supporting analysis.
Nevertheless, as Cannanda’s terpene mix is proprietary, we’re unable to offer a transparent evaluation of effectiveness or speculate as to the concentrating on of the formulation (basic use, power, and so on.).
By relying solely on terpenes—so far as hemp-derived compounds are involved—to create their CB2 oil, Cannanda is certainly in a position to sidestep a few of the security and regulatory hurdles that have an effect on normal CBD.
Together with the general public, we’d prefer to see extra analysis confirming the effectiveness of this terpene mix to sharpen the comparability in opposition to CBD, however for now, we’ll control Cannanda to see the place they go along with this.
